Ушбу ишга иқтибос қилган ишлар

5 та иш

Иш: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

1. The state of lipid metabolism in patients with diabetic nephropathy

   Lola Daminova, Sitora Muminova, Bakhodir Nigmonov

   МақолаLiver Disease Diagnosis and TreatmentArchives of Gerontology and Geriatrics Plus20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.008680

2. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Шарҳ мақолаLipoproteins and Cardiovascular HealthAtherosclerosis20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000004

3. Duration of the hypolipidemic effect after the course of intravenous laser therapy in patients with lipid metabolism disorders

   A. A. Achilov, S. V. Gornov, D. U. Usmonzoda +5

   МақолаLaser Applications in Dentistry and MedicineLaser Medicine20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.016750

4. Meta Analysis of <scp>DHA</scp> and <scp>EPA</scp> Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk

   Sepideh Karkon Shayan, Rosull Saadoon Abbood, Sarah F. Al‐Taie +10

   МақолаFatty Acid Research and HealthPharmacology Research & Perspectives20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.018570

5. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

   Christian Bork, Børge G. Nordestgaard, Berit Storgaard Hedegaard +67

   МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.020412